Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 2, 2016 | $49.3B |
| FY2017, ended Dec 1, 2017 | $88.2B |
| FY2018, ended Nov 30, 2018 | $122B |
| FY2019, ended Nov 29, 2019 | $149B |
| FY2020, ended Nov 27, 2020 | $228B |
| FY2021, ended Dec 3, 2021 | $291B |
| FY2022, ended Dec 2, 2022 | $156B |
| FY2023, ended Dec 1, 2023 | $277B |
| FY2024, ended Nov 29, 2024 | $225B |
| FY2025, ended Nov 28, 2025 | $131B |
| Trailing 12 months to Aug 28, 2026 (through Q3 FY2026) | $113B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 2, 2016 | $5.85B |
| FY2017, ended Dec 1, 2017 | $7.30B |
| FY2018, ended Nov 30, 2018 | $9.03B |
| FY2019, ended Nov 29, 2019 | $11.2B |
| FY2020, ended Nov 27, 2020 | $12.9B |
| FY2021, ended Dec 3, 2021 | $15.8B |
| FY2022, ended Dec 2, 2022 | $17.6B |
| FY2023, ended Dec 1, 2023 | $19.4B |
| FY2024, ended Nov 29, 2024 | $21.5B |
| FY2025, ended Nov 28, 2025 | $23.8B |
| Trailing 12 months to Aug 28, 2026 (through Q3 FY2026) | $26.0B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 2, 2016 | $1.17B | $2.00B |
| FY2017, ended Dec 1, 2017 | $1.69B | $2.73B |
| FY2018, ended Nov 30, 2018 | $2.59B | $3.76B |
| FY2019, ended Nov 29, 2019 | $2.95B | $4.03B |
| FY2020, ended Nov 27, 2020 | $5.26B | $5.31B |
| FY2021, ended Dec 3, 2021 | $4.82B | $6.88B |
| FY2022, ended Dec 2, 2022 | $4.76B | $7.40B |
| FY2023, ended Dec 1, 2023 | $5.43B | $6.94B |
| FY2024, ended Nov 29, 2024 | $5.56B | $7.87B |
| FY2025, ended Nov 28, 2025 | $7.13B | $9.85B |
| Trailing 12 months to Aug 28, 2026 (through Q3 FY2026) | $7.28B | $10.6B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 2, 2016 | $1.01B |
| FY2017, ended Dec 1, 2017 | $2.31B |
| FY2018, ended Nov 30, 2018 | $1.64B |
| FY2019, ended Nov 29, 2019 | $2.65B |
| FY2020, ended Nov 27, 2020 | $4.48B |
| FY2021, ended Dec 3, 2021 | $3.84B |
| FY2022, ended Dec 2, 2022 | $4.24B |
| FY2023, ended Dec 1, 2023 | $7.14B |
| FY2024, ended Nov 29, 2024 | $7.61B |
| FY2025, ended Nov 28, 2025 | $5.43B |
| Trailing 12 months to Aug 28, 2026 (through Q3 FY2026) | $4.36B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 2, 2016 | $1.89B |
| FY2017, ended Dec 1, 2017 | $1.88B |
| FY2018, ended Nov 30, 2018 | $4.12B |
| FY2019, ended Nov 29, 2019 | $989M |
| FY2020, ended Nov 27, 2020 | $4.12B |
| FY2021, ended Dec 3, 2021 | $4.12B |
| FY2022, ended Dec 2, 2022 | $3.63B |
| FY2023, ended Dec 1, 2023 | $3.63B |
| FY2024, ended Nov 29, 2024 | $4.13B |
| FY2025, ended Nov 28, 2025 | $6.21B |
| Trailing 12 months to Aug 28, 2026 (through Q3 FY2026) | $4.77B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 21.2% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 2, 2016 | 494M |
| FY2017, ended Dec 1, 2017 | 492M |
| FY2018, ended Nov 30, 2018 | 488M |
| FY2019, ended Nov 29, 2019 | 482M |
| FY2020, ended Nov 27, 2020 | 479M |
| FY2021, ended Dec 3, 2021 | 472M |
| FY2022, ended Dec 2, 2022 | 458M |
| FY2023, ended Dec 1, 2023 | 452M |
| FY2024, ended Nov 29, 2024 | 435M |
| FY2025, ended Nov 28, 2025 | 411M |
| Trailing 12 months to Aug 28, 2026 (through Q3 FY2026) | 389M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 2, 2016 | $1.07B | $349M |
| FY2017, ended Dec 1, 2017 | $1.10B | $454M |
| FY2018, ended Nov 30, 2018 | $2.05B | $610M |
| FY2019, ended Nov 29, 2019 | $2.75B | $788M |
| FY2020, ended Nov 27, 2020 | $3.05B | $909M |
| FY2021, ended Dec 3, 2021 | $3.95B | $1.07B |
| FY2022, ended Dec 2, 2022 | $6.55B | $1.44B |
| FY2023, ended Dec 1, 2023 | $4.40B | $1.72B |
| FY2024, ended Nov 29, 2024 | $9.50B | $1.83B |
| FY2025, ended Nov 28, 2025 | $11.3B | $1.94B |
| Trailing 12 months to Aug 28, 2026 (through Q3 FY2026) | $9.29B | $2.07B |
Valuation
At current price- Market Cap
- $96.7B
- P/E
- 13.3×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 3.7×
- Price / Book
- 8.2×
- EV / EBITDA
- 9.7×
Growth
Trailing 12 months- Revenue (TTM)
- $26.0B
- Revenue Growth YoY
- 12.0%
- Revenue CAGR 3Y
- 10.5%
- Revenue CAGR 5Y
- 13.1%
- EPS Growth YoY
- 11.7%
- Net Income Growth YoY
- 4.7%
Profitability
Trailing 12 months- Gross Margin
- 89.3%
- Operating Margin
- 35.7%
- Net Margin
- 28.0%
- FCF Margin
- 40.8%
- Return on Equity
- 61.9%
Earnings
Trailing 12 months- Net Income
- $7.28B
- EPS (diluted)
- $17.91
- EBITDA
- $10.0B
- Operating Income
- $9.27B
Balance Sheet
As of Aug 28, 2026- Cash and cash equivalents
- $4.36B
- Total Debt
- $4.77B
- Net Debt
- $407M
- Total Assets
- $30.0B
- Total Liabilities
- $18.2B
- Shareholders' Equity
- $11.8B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $10.8B
- Capital Expenditure
- $214M
- Free Cash Flow
- $10.6B
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- 1.41
Every ratio is calculated from the company’s reported figures.